reports
- GlobalData Healthcare Department
OncoSec Medical Inc (ONCS) - Financial Analysis Review
Summary OncoSec Medical Inc (ONCS) - Financial Analysis Review Summary OncoSec Medical Inc (OncoSec) is a biotechnology company which provides services to stimulate body’s immune system and attack cancer. It’s lead candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through in vivo electroporation. OncoSec is conducting pipeline programs for various indications which include metastatic melanoma, trip...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.